Jen‐Tsan Chi

16.9k citations
146 papers · 11.7k indexed · 4 hit papers · h-index 53

Impact in

    • Cancer, Hypoxia, and Metabolism
    • Cancer-related molecular mechanisms research
    • MicroRNA in disease regulation
    • Cancer, Lipids, and Metabolism
    • RNA modifications and cancer
    • Epigenetics and DNA Methylation

Papers in

    • Cancer, Hypoxia, and Metabolism 28
    • Cancer-related molecular mechanisms research 14
    • Cancer, Lipids, and Metabolism 10
    • Hippo pathway signaling and YAP/TAZ 13

Jen‐Tsan Chi

140 papers receiving 11.5k citations

Hit Papers

The Hippo Pathway Effector TAZ Regulates Ferroptosis in Renal Cell Carcinoma 2019 · 363 citations
3632002202620102018250500750

Peers

Jen‐Tsan Chi
Comparison fields: 5 of 153
  • Cancer Research 4.6k
  • Molecular Biology 7.1k
  • Oncology 1.8k
  • Pulmonary and Respiratory Medicine 2.0k
  • Cell Biology 1.0k
Replace Linda Z. Penn with:
Linda Z. Penn Canada
Alexandra Giatromanolaki Greece
Naohiko Seki Japan
Roy Bicknell United Kingdom
Michael I. Koukourakis Greece
Helen Turley United Kingdom
Adriana Haimovitz‐Friedman United States
Jane B. Trepel United States
Rork Kuick United States
Colin C. Collins Canada
Jen‐Tsan Chi relative to Linda Z. Penn Canada Linda Z. Penn's profile →
Citations per field
00.5×2.8×
Linda Z. Penn · 1×
Citations per year

Countries citing papers authored by Jen‐Tsan Chi

Since Specialization
Citations

This map shows the geographic impact of Jen‐Tsan Chi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jen‐Tsan Chi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jen‐Tsan Chi more than expected).

Fields of papers citing papers by Jen‐Tsan Chi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jen‐Tsan Chi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jen‐Tsan Chi. The network helps show where Jen‐Tsan Chi may publish in the future.

Co-authors

The 25 scholars most cited alongside Jen‐Tsan Chi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Jen‐Tsan Chi Line = papers co-authored together Jen‐Tsan Chi links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20250
2 20240
3 20227
4 20216
5 202044
6 20204
7 2019235
8 201960
9
The Hippo Pathway Effector TAZ Regulates Ferroptosis in Renal Cell Carcinoma
Hit paper breakdown →
2019363
10 201789
11 201785
12 201667
13 201534
14 201520
15 20149
16 201222
17 2011456
18 201186
19 201127
20 2003220

About Jen‐Tsan Chi

Jen‐Tsan Chi is a scholar working on Cancer Research, Cell Biology, Molecular Biology, Biochemistry and Hematology, having authored 146 papers that have together received 11.7k indexed citations. Recurring topics across this work include Cancer, Hypoxia, and Metabolism (28 papers), RNA modifications and cancer (27 papers), Ferroptosis and cancer prognosis (16 papers), Epigenetics and DNA Methylation (14 papers), Cancer-related molecular mechanisms research (14 papers), Hippo pathway signaling and YAP/TAZ (13 papers), Cancer, Lipids, and Metabolism (10 papers) and RNA Research and Splicing (10 papers). The work is most often cited by research in Cancer Research (4.6k citations), Molecular Biology (7.1k citations), Oncology (1.8k citations), Pulmonary and Respiratory Medicine (2.0k citations) and Cell Biology (1.0k citations). Jen‐Tsan Chi has collaborated with scholars based in United States, Taiwan and China. Frequent co-authors include Patrick O. Brown, Howard Y. Chang, David Botstein, Matt van de Rijn, Wen‐Hsuan Yang, Jianli Wu, Chien‐Kuang Cornelia Ding, Chao‐Chieh Lin, Marilyn J. Telen and Carolyn Sangokoya. Their work appears in journals such as PLoS ONE, PLoS Genetics, Cancer Research, Proceedings of the National Academy of Sciences and Nature Communications.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026